Buprenorphine Treatment Centers in Wyoming

No age cap. Patients in their 60s, 70s, and 80s successfully receive buprenorphine in Wyoming. Older adults may need dose adjustments, additional ECG screening (for methadone), or monitoring for interactions with chronic-disease medications, but age alone is not a barrier.

Free buprenorphine treatment is possible in Wyoming for patients who qualify for Wyoming Medicaid, are enrolled in State Opioid Response–funded clinics, or use charity-care programs at community behavioral-health centers. Call 988 or 1-800-662-4357 for live referrals.

No. Drug screens performed as part of an MAT program are covered by Wyoming Medicaid without an additional patient copay. The clinic bills Wyoming Medicaid directly; patients should not receive separate drug-screen bills.

You may owe the full charge minus any out-of-network benefit. Ask buprenorphine providers whether they will file an insurance claim, charge you up-front, or negotiate a single-case agreement with your insurer. No Surprises Act protections may apply — request a Good Faith Estimate.

Wyoming’s state behavioral-health authority licenses MAT facilities, and the Substance Abuse and Mental Health Services Administration (SAMHSA) certifies Opioid Treatment Programs. The Drug Enforcement Administration (DEA) regulates controlled-substance handling at every MAT site.

Nationwide average MAT retention is about 6–18 months; the strongest outcomes occur in patients retained beyond 12 months. Wyoming State Opioid Response data reports rising average retention since 2021 as hub-and-spoke models mature.

Many Wyoming OTPs and low-barrier clinics accept walk-ins during intake hours. Others require an appointment; call first to confirm. Walk-in availability is most common at federally qualified health centers and State Opioid Response–funded bridge clinics.

Most patients feel calm relief of withdrawal rather than euphoria. Mild drowsiness is common the first day; avoid driving or operating machinery until you know how you react. Severe sedation is rare and warrants a call to the Wyoming clinic.

Yes. Benzodiazepines, alcohol, and some sleep medications significantly increase sedation risk. HIV medications and certain antibiotics can alter methadone levels. Always share your full medication list with the Wyoming MAT clinician so interactions can be managed.

Yes. Starting MAT during pregnancy is strongly recommended for patients with OUD. Wyoming perinatal-addiction programs offer priority same-day access; OB-MAT coordinated care improves maternal and infant outcomes dramatically compared to untreated OUD.

Yes — counseling records are protected by 42 CFR Part 2 and HIPAA. The counselor cannot disclose your MAT status or session content to family, employer, or law enforcement without your specific written consent or a narrowly tailored court order.

Yes, with proper documentation. Bring a letter from your Wyoming MAT prescriber, medication in its original pharmacy container, and check destination-country rules — some countries restrict methadone and buprenorphine. The International Narcotics Control Board maintains destination-country guidance.